To report speech outcomes following Orticochea pharyngoplasty in 43 patients with cleft palate and noncleft velopharyngeal dysfunction.
Design:
A retrospective surgical audit of patients undergoing Orticochea pharyngoplasty between 2004 and 2012, with speech as a primary outcome measure.
Setting:
Patients known to a regional UK cleft center.
Methods:
Forty-three patients underwent Orticochea pharyngoplasty by a single surgeon in a UK regional cleft center. Twenty-one patients had undergone a prior procedure for velopharyngeal dysfunction. Pre- and postoperative speech samples were assessed blindly using the Cleft Audit Protocol for Speech-Augmented by a specialist cleft speech and language therapist, external to the team. Speech samples were rated on the following parameters: hypernasality, hyponasality, audible nasal emission, nasal, turbulence, and passive cleft speech characteristics. Statistical differences in pre- and postoperative speech scores were tested using the Wilcoxon matched-pairs signed-ranks test. Inter- and intrareliability scores were calculated using weighted Cohen κ.
Results:
Whole group: A statistically significant difference in pre- and postoperative scores for hypernasality (P < .001), hyponasality (P < .05), nasal emission (P < .01), and passive cleft speech characteristics (P < .01) were reported. Patients with cleft diagnoses: A statistically significant difference in scores for hypernasality (P < .001), nasal emission (P < .01), and passive cleft speech characteristics (P < .01) were reported for this group of patients. Patients with noncleft diagnoses: The only parameter to demonstrate a statistically significant difference was hypernasality (P < .01) in this group.
Conclusions:
Orticochea pharyngoplasty is a successful surgical procedure in treating velopharyngeal dysfunction in both the cleft and noncleft populations.
AhlRAhmadTHarding-BellAWhartonLJordanAHallP. The buccinator mucomuscular flap: an in-depth analysis and evaluation of its role in the management of velopharyngeal dysfunction. Cleft Palate Craniofac J. 2016;53(5):177–184.
2.
AhlRHarding-BellA. Comparing methodologies in a series of speech outcome studies: challenges and lessons learned. Cleft Palate Craniofac J. 2018;55(1):35–44.
3.
AlivuotilaLHakokariJVisnapuuVKorpijaakko-HuuhkaAMAaltonenOHapponenRPPeltonenSPeltonenJ. Speech characteristics in neurofibromatosis type 1. Am J Med Genet A. 2010;152(1):42–51.
4.
AltmanDG. Practical Statistics for Medical Research. CRC Press; 1990.
5.
American Speech-Language Hearing Association (ASHA). Childhood Apraxia of Speech (Technical Report). Published2007. http://www.asha.org/policy20071-74
6.
BaylisAMunsonBMollerK. Factors affecting articulation skills in children with velocardiofacial syndrome and children with cleft palate or velopharyngeal dysfunction: a preliminary report. Cleft Palate Craniofac J. 2008;45(2):193–207.
7.
BaylisAShribergLD. Estimates of the Prevalence of Speech and Motor Disorders in youth with 22q.11.2 Deletion Syndrome. Am J Speech Lang Pathol. 2019;38;53–82.
8.
BaylisALWatsonPJMollerKT. Structural and functional causes of hypernasality in velocardiofacial syndrome. Folia Phoniatr Logop. 2009;61(2):93–96.
9.
BonetiCRayPDMacklemEBKohanzadehSde la TorreJGrantJH. Effectiveness and safety of autologous fat grafting to the soft palate alone. Ann Plast Surg. 2015;74(suppl 4):S190–S192.
10.
ChegarBETatumSAMarrinanEShprintzenRJ. Upper airway asymmetry in velo-cardio-facial syndrome. Int J Pediatr Otorhinolaryngol. 2006;70(8):1375–1381.
11.
ClarkMHarrisRJolleffNPriceKNevilleBG. Worster-drought syndrome: poorly recognized despite severe and persistent difficulties with feeding and speech. Dev Med Child Neurol. 2010;52(1):27–32.
12.
D’AntonioLLSchererNJMillerLLKalbfleischJHBartleyJA. Analysis of speech characteristics in children with velocardiofacial syndrome (VCFS) and children, with phenotypic overlap without VCFS. Cleft Palate Craniofac J. 2001;38(5):455–467.
13.
De BlacamCBaylisALKirschnerRESellDSieKCYHarrisHEOrrDJA. Protocol for the development of a core outcome set for reporting outcomes of management of velopharyngeal dysfunction. BMJ Open. 2020;10(8):e036824.
14.
De BlacamCSmithSOrrD. Surgery for velopharyngeal dysfunction: a systematic review of interventions and outcomes. Cleft Palate Craniofac J. 2018;55(3):405–422.
15.
DenadaiRSabbagARaposo-AmaralCAFilhoJCPNagaeMHRaposo-AmaralCA. Bilateral buccinator myomucosal flap outcomes in nonsyndromic patients with repaired cleft palate and velopharyngeal insufficiency. J Plast Reconstr Aesthet Surg. 2017;70(11):1598–1607.
16.
EzzatAEMKhalifaRAAkelMMHannaM. Functional and speech outcomes of superiorly based flap pharyngoplasty combined with radical intravelar veloplasty. J Cleft Lip Palate Craniofacial Anomalies. 2015;2(1):41–48.
17.
FilipCMatzenMAuknerRMoeMHogevoldHEAbyholmFAbrahamsenTGTonsethK. Superiorly based pharyngeal flap for treatment of velopharyngeal insufficiency in patients with 22q11.2 deletion syndrome. J Craniofac Surg. 2013;24(2):501–504.
18.
GolinkoMSMasonKNettKRiskiJWilliamsJ. Sphincterplasty for velopharyngeal insufficiency in the child without a cleft-palate: aetiologies and speech outcomes. J Craniofac Surg. 2015;26(7):2067–2071.
19.
GroverRBarnettARampazzoAPapayFGharbB. Outcomes of Sphincter Pharyngoplasty in the Cleft Population. J Craniofac Surg. 2018;29(4):908–913.
20.
HenningssonGEIsbergAM. Velopharyngeal movement patterns in patients alternating between oral and glottal articulation: a clinical and cineradiographical study. Cleft Palate J. 1986;23(1):1–9.
21.
HensGSellDPinkstoneMBirchMJHayNSommerladBC. Palate Lengthening by Buccinator Myomucosal Flaps for Velopharyngeal Insufficiency. Cleft Palate Craniofac J. 2013;50(5):e84–e91.
22.
HodgkinsNHooCMcGeePHillC. A survey of assessment and management of velopharyngeal incompetence (VPI) in the UK +Ireland. J Plast Reconstr Aesthet Surg. 2015;68(4):485–491.
23.
HynesW. Pharyngoplasty by muscle transplantation. Br J Plast Surg. 1950;3(2):128–135.
24.
IBM Corp. IBM SPSS Statistics for Windows, Version 25.0. IBM Corporation; 2017.
JamesNTwistMMilwardTMTurnerMM. An audit of velopharyngeal incompetence treated by the orticochea pharyngoplasty. Br J Plast Surg. 1996;49(4):197–201.
27.
JohnASellDSweeneyTHarding-BellAWilliamsA. The Cleft Audit Protocol for Speech –Augmented: A validated and reliable measure for auditing Cleft Speech. Cleft Palate Craniofac J. 2006;43(3):272–281.
KummerAWCurtisCWiggsMLeeLStrifeJL. Comparison of velopharyngeal gap size in patients with hypernasality, hypernasality and nasal emission or nasal turbulence (rustle) as the primary speech characteristic. Cleft Palate Craniofac J. 1992;29(2):152–156.
30.
KummerAWLeeLStutzLSMaroneyABrandtJW. The prevalence of apraxia characteristics in patients with velocardiofacial syndrome as compared with other cleft populations. Cleft Palate Craniofac J. 2007;44(2):175–181.
31.
LendrumJDharBK. The orticochea dynamic pharyngoplasty. Br J Plast Surg. 1984;37(2):160–168.
32.
LorchMFernerRGoldingJWhurrR. The nature of speech and language impairment in adults with neurofibromatosis 1. J Neurolinguistics. 1999;12(3-4):157–165.
33.
LoskenAWilliamKBursteinF.DMalickBSRiskiJE. An outcome evaluation of sphincter pharyngoplasty for the management of velopharyngeal insufficiency. Plast Reconstr Surg. 2003;112(7):1755–1761.
MehendaleFVBirchMJBirkettLSellDSommerladBC. Surgical management of velopharyngeal incompetence in VCFS. Cleft Palate Craniofac J. 2004;42(2):129–139.
36.
MilczukHSmithDBrockmanJ. Surgical Outcomes for velopharyngeal insufficiency in velocardiofacial syndrome and non-syndromic patients. Cleft Palate Craniofac J. 2007;44(4):412–417.
37.
MillsLGoslingASellD. Extending the communication phenotype associated with 22q11.2 microdeletion syndrome. Int J Speech Lang Pathol. 2006;8(1):17–27.
38.
NaranSFordMLoseeJE. What’s new in cleft palate and velopharyngeal dysfunction management?. Plast Reconstr Surg. 2017;139(6):1343e–1355e.
39.
NayarHSCrayJJMacIsaacZMArgentaAEFordMDFentonRALoseeJEGrunwaldtLJ. Improving speech outcomes after failed palate repair: evaluating the safety and efficacy of conversion furlow palatoplasty. J Craniofac Surg. 2014;25(2):343–347.
40.
OrticocheaM. Construction of a dynamic muscle sphincter in cleft palates. Plast Reconstr Surg. 1968;41(4):323–327.
41.
OrticocheaM. Results of the dynamic muscle sphincter operation in cleft palates. Br J Plast Surg. 1970;23(2):108–114.
42.
ParkMAhnSHJeongJHBaekRM. Evaluation of the levator veli palatini muscle thickness in patients with velocardiofacial syndrome using magnetic resonance imaging. J Plast Reconstr Aesthet Surg. 2015;68(8):1100–1105.
43.
PerssonCLaaksoKEdwardssonHLindblomJHarteliusL. Signs Of dysarthria in Adults with 22q11 deletion syndrome. Am J Med Genet A. 2016;173(3):618–626.
44.
PerssonCLohmanderAJönssonROskarsdóttirSSöderpalmE. A prospective cross-sectional study of speech in patients with the 22q11 deletion syndrome. J Commun Disord. 2003;36(1):13–47.
45.
Prada-MadridJRGomez OrtegaVEcheverriPLondono VelasquezN. Prevalence of obstructive sleep apnea after orticochea pharyngoplasty for velopharyngeal insufficiency management. Cleft Palate Craniofac J. 2018;52(6):682–687.
46.
PryorLSLehmanJParkerMGSchmidtAFoxLMurthyAS, Outcomes in pharyngoplasty: a 10 year experience. Cleft Palate Craniofac J. 2006;43(2):222–225.
47.
RiskiJERuffGIGeorgiadeGSBarwickWJEdwardsPD. Evaluation of sphincter pharyngoplasty. Cleft Palate Craniofac J. 1992;29(3):254–261.
48.
RouillonILeboulangerNRogerGMauletMMarlinSLoundoNPortnoïMDenoyelleFGarabédianE. Velopharyngoplasty for noncleft velopharyngeal insufficiency. Arch Otolaryngol Head Neck Surg. 2009;135(7):652–656.
49.
SealyLRGiddensCL. Aerodynamic indices of velopharyngeal function in childhood apraxia of speech. Clin Linguist Phon. 2009;24(6):417–430.
50.
SellDHardingAGrunwellP. GOS.SP.ASS.’98: an assessment for speech disorders associated with cleft palate and/or velopharyngeal dysfunction (revised.). Int J Lang Commun Disord. 1999;34:17–33.
51.
SellDJohnAHarding-BellASweeneyTHegartyFFreemanJ. Cleft audit protocol for speech: a comprehensive training package for speech analysis. Int J Lang Commun Disord. 2009;44(4):529–548.
SetabutrDRothCTNolenDDCervenkaBSykesJMSendersCWTollefsonTT. Revision rates and speech outcomes following pharyngeal flap surgery for velopharyngeal insufficiency. JAMA Facial Plast Surg. 2015;17(3):197–201.
54.
SieKTampakopoulouDASerresMDGrassJS. Sphincter pharyngoplasty: speech outcomes and complication. Laryngoscope. 1998;108(8):1211–1217.
55.
SimJWrightCC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85(3):257–268.
56.
SkirkoJRWeaverEMPerkinsJ. Modification and evaluation of a velopharyngeal insufficiency quality of life instrument. Arch Otolaryngol Head Neck Surg. 2012;138 (10):929–935.
57.
SobinCMonkSHKiley-BrabeckKKhuriJKarayjorgouM. Neuromotor deficits in children with the 22q11 deletion syndrome. Mov Disord. 2006;21(12):2082–2089.
58.
SolotCSellDMayneABaylisALPerssonCJacksonOMcDonald-McGinnjkDA. Speech-language disorders in 22q11.2 deletion syndrome: best practices for diagnosis and management. Am J Speech Lang Pathol. 2019;28(3):984–999.
59.
SolotCBGerdesMKirschnerREMcDonald-McGinnDMMossEWoodinMWangPP. Communication issues in 22q11.2 deletion syndrome: Children at risk. Genet Med. 2001;3(1):67–71.
60.
SpruijtNEReijmanHinzeJHensGVander-PoortenVvan der MolenABM. In search of the optimal surgical treatment for velopharyngeal dysfunction in 22q11.2 Deletion syndrome: a systematic review. PLoS One. 2012;7(3). doi:10.1371/journal.pone.0034332
61.
SwansonEWSullivanSRRidgwayEBMarrinanEMMullikenJB. Speech outcomes following pharyngeal flap in patients with velocardiofacial syndrome. Plast Reconstr Surg. 2011;127(5):2045–2053.
62.
ThompsonHLViskochilDHStevensonDAChapmanKL. Speech-language characteristics of children with neurofibromatosis type 1. Am J Med Genet A. 2010:152(2):284–290.
63.
VisnapuuVPeltonenSAlivuotilaAHapponenRPPeltonenJ. Craniofacial and oral alterations in patients with neurofibromatosis 1. Orphanet J Rare Dis. 2018;13(1);131.
64.
WiddershovenJCStubenitskyBMBreugemCCMinkvanderMolenAB. Outcome of velopharyngoplasty in patients with velocardiofacial syndrome. Arch Otolaryngol Head Neck Surg. 2008;134(11):1159–1164.
65.
WiddershovenJCCSolotCBMcDonald-McGinnDMZackaiEHKirschnerRE. Surgical management of velopharyngeal dysfunction in patients with 22q11.2 deletion syndrome. Cleft Palate Craniofac J. 2012;49(4):447–455.
66.
Wong RiffKWTsangarisEGoodacreTForrestCRPusicALCanoSJKlassenAF. International multiphase mixed methods study protocol to develop a cross-cultural patient-reported outcome instrument for children and young adults with cleft lip and/or palate (CLEFT-Q). BMJ Open. 2017;7(1):e015467.
67.
YsunzaAPamplonaCDrukerMMolinaFFelemoviciusJRamirezEPatinoC. Surgery for speech in cleft palate patients. Int J Pediatr Otorhinolaryngol. 2004;68(12):1499–15047.
